Your Primer to Healthcare Mergers and Acquisitions

Category: Healthcare Sectors

Exit Planning, Healthcare Sectors
Selling Your Human Services Company: 8 FAQs and Their Answers

I often receive calls from owners of human services companies who say something along the lines of, "I don't know what I don't know" concerning selling their company. What's important to understand is that it's okay not to know everything about selling a company. It's a complex process, which is why most successful sales involve a team working together toward a common goal.

Read More
Healthcare Sectors, Market Trends
8 Pharmacy Trends From 2020 That Are Here To Stay

As we approach the end of year, it's a good time to look back and identify some of the more significant pharmaceutical developments from 2020 that are playing a role in influencing or reshaping the industry. Here are eight noteworthy trends that emerged or gained steam this year that are likely to follow us into 2021 and beyond.

Read More
Exit Planning, Healthcare Sectors, Market Trends
Risk and Uncertainty for Durable Medical Equipment: 3 Issues to Watch

While I would never claim to have a crystal ball, I can tell you that there are a few issues that will likely have significant effects on respiratory-focused durable medical equipment (DME) companies going into and during 2021. Here are three that stand out.

Read More
Healthcare Sectors, Market Trends
Healthcare Business Leaders on the Short- and Long-Term Effects of COVID-19

How is the COVID-19 pandemic going to affect healthcare businesses in the short and long term? We asked leaders from several companies to share their responses to this question, which are below. Following these responses, David Coit of VERTESS shares his thoughts about how the health crisis is affecting healthcare business valuation.

Read More
Healthcare Sectors, Market Trends
Ambulatory Surgery Centers: 6 Reasons for Optimism During COVID-19

Much has been said about the social and business opportunities buried within the COVID-19 crisis. Who hasn't been on a video conference when someone tried to invoke Sir Winston Churchill's quote: "Never let a good crisis go to waste."

Read More
Healthcare Sectors, Market Trends
COVID-19 Roundtable With IDD Leaders: Key Takeaways

In the middle of May, I had the opportunity to participate in a conference call with leaders in the field of providing support services to individuals affected by intellectual and/or developmental disabilities (IDD) during which we discussed the impact of COVID-19 on our services. This group consisted of direct service providers, area agency/managed care providers, and those who help with consulting and/or planning services. Representatives shared their current perspective of COVID-19 and how their services were affected, how they are planning for the "next phase" of communities opening back up, and the possibility of another lockdown.

Read More
Healthcare Sectors, Market Trends
Home Medical Equipment Providers: An Underappreciated Solution (Until Now)

While home medical equipment (HME) providers are well-recognized for adapting to change, especially as insurance companies shift requirements and the healthcare industry matures, what happened with COVID-19 blindsided everyone. Planning and projections went out the window. Now, we're trying to settle into a "new normal" that keeps changing.

Read More
Healthcare Sectors, Market Trends
Resilience and Growth in Human Services & Healthcare During COVID-19

By mid-to-late March, we all felt the immediate effects of the "lockdown" of our communities. Some healthcare businesses stopped services entirely while others saw a large dip in those offered. Organizations with a diversified payor source probably fared better than single-source providers, everyone felt the effects. At VERTESS, we had some deals stop, some slowed or paused, and others moved along. Progress — or lack thereof — all depended on the confidence of the buyer and ability of the seller to adjust.

Read More
Healthcare Sectors, Market Trends
7 Noteworthy Coronavirus News Developments for Pharmacies

While all of healthcare has been hit hard by the rapid spread of the novel coronavirus, some industries have been affected more than others. Much of the news has focused on the impact to those facilities providing care to clients and patients, such as nursing homes, senior living, hospitals, and urgent care centers, there's another industry that's been greatly impacted but is under the radar: pharmacy.

Read More
Exit Planning, Healthcare Sectors, Valuation
Thinking of Selling Your Urgent Care Center?

The healthcare industry is continually in flux. Business owners and operators of urgent care centers (UCCs) are constantly experiencing changing regulatory guidelines and suppressing reimbursement from payors. These unpreventable changes and a demanding environment may lead owners to seek monetization of their assets. For those UCC owners considering selling, there's good news: The marketplace is currently hungry for your companies and buyers are eagerly gobbling up well-performing UCCs.

Read More
Healthcare Sectors, Market Trends
Integrated Care: No Need To Fear What We Already Know

Integrated care is one of the big buzz words in the human services industry. Integrated care is fundamentally the combination of primary healthcare and mental healthcare in a single setting for the purpose of creating a team-based approach to general and mental care. As managed care becomes more commonplace in human services, payers are pressing for its providers to achieve the objectives of integrated care. As a result, providers are finding themselves tasked with the challenge of further decreasing cost while improving outcomes for those receiving support services.

Read More
Healthcare Sectors
Fall of Diplomat Pharmacy: 10 Things That Went Wrong

In July 2015, Diplomat Pharmacy was the talk of the town. Momentum seemed like it was on the company's side, with Diplomat looking poised to be a major player for many years to come. But, as it is often said, "the higher they rise, the harder they fall." In December 2019, UnitedHealth Group's OptumRx agreed to acquire Diplomat for about $4 a share in cash. What caused this "All-American success story" to come up so short on expectations?

Read More
1 2 3 7

Committed to Constant Improvement?

Subscribe to our bi-weekly newsletter – SalientValue

No Spam Ever. We Promise.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram